Jerod Denton Archive — Page 1 of 1

August 17, 2023

Grant aids drug discovery for autism, schizophrenia

Federal grant to help Vanderbilt researchers will pave the way for potential treatments for schizophrenia and autism spectrum disorder

By Paul Govern
May 25, 2017

Vanderbilt, Ono Pharmaceutical extend drug discovery agreement

Vanderbilt University Medical Center (VUMC), Vanderbilt University and Japan-based Ono Pharmaceutical Co. Ltd. have expanded a drug discovery agreement initiated in 2015 that will now run through 2019.

By Vanderbilt Health News
March 23, 2017

Emerging Scholar

Rene Raphemot, Ph.D., a National Institutes of Health postdoctoral fellow at Duke University, delivered the inaugural Discovery Science Emerging Scholars Lecture at Vanderbilt University School of Medicine last week.

By Vanderbilt Health News
December 1, 2016

Investigators explore new way to control mosquitoes

In a new study, Vanderbilt pharmacologist Jerod Denton, Ph.D., Ohio State entomologist Peter Piermarini, Ph.D., and colleagues report an experimental molecule that inhibits kidney function in mosquitoes and thus might provide a new way to control the deadliest animal on Earth.

By Paul Govern
December 10, 2015

Vanderbilt, Ono Pharmaceutical sign drug discovery agreement

Vanderbilt University Medical Center and Ono Pharmaceutical Group, an international company based in Japan, have signed a drug discovery agreement.

By Paul Govern
April 16, 2014

Channel drug restores glucose balance

A new compound that activates potassium channels could be used to treat disorders of glucose homeostasis.

By Bill Snyder